Our spinouts


Pulmagen Therapeutics is a development stage pharmaceutical company progressing novel therapies to treat chronic respiratory diseases including asthma, severe asthma, and COPD.

The company has developed a portfolio of clinical programmes targeting chronic respiratory diseases including severe persistent asthma, allergic asthma and Chronic Obstructive Pulmonary Disease (COPD). Such pulmonary diseases are characterised by reduced lung function and underlying chronic pulmonary inflammation.